Discriminative Ability of CHA2DS2-VASc and HAS-BLED Score in Whites and Nonwhites

被引:1
|
作者
Schwartz, Sarah M. [1 ]
Tedla, Yacob G. [1 ]
Greenland, Philip [1 ,2 ]
Yadlapati, Ajay [3 ]
Passman, Rod S. [1 ,2 ]
机构
[1] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA
[3] South Denver Cardiol Associates, Littleton, CO USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2019年 / 123卷 / 12期
关键词
ATRIAL-FIBRILLATION; RISK STRATIFICATION; AFRICAN-AMERICAN; STROKE; WARFARIN; THROMBOEMBOLISM; DISEASE;
D O I
10.1016/j.amjcard.2019.03.020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The CHA(2)DS(2)-VASc and HAS-BLED scoring systems are used in patients with atrial fibrillation (AF) to estimate risk of stroke and bleeding, respectively. Both were developed in minimally diverse European populations and these scores have not yet been extensively studied in US whites and nonwhites. In a retrospective cohort study, we included patients with AF who received inpatient or outpatient care in a large integrated academic health system from 2011 to 2017. Cox proportional hazards were used to analyze associations between stroke and CHA(2)DS(2)-VASc score in AF patients not prescribed anticoagulation and between incident bleeding and HAS-BLED score in anticoagulated patients. After exclusions for previous stroke, the cohort included 21,648 patients with a mean age of 66.8 +/- 15.8. Anticoagulation was prescribed in 52% of whites and 46% of nonwhites (p < 0.001) with a CHA(2)DS(2)-VASc score of >= 2. Mean CHA(2)DS(2)-VASc scores were 2.4 +/- 1.6 in whites and 2.2 +/- 1.6 in nonwhites and mean HAS-BLED scores was 1.5 +/- 1.1 in whites and 1.3 +/- 1.0 in nonwhites. After adjusting for baseline differences, the discriminative ability of CHA(2)DS(2)-VASc and HAS-BLED was similar in whites and nonwhites (p = 0.52, 0.33, respectively). The discriminative ability of HAS-BLED was similar in patients on vitamin K antagonists and direct oral anticoagulants. In conclusion, oral anticoagulation was prescribed less frequently in nonwhites. However, the discriminative ability of CHA(2)DS(2)-VASc and HAS-BLED were similar in whites and nonwhites. (C) 2019 Elsevier Inc. All rights reserved.
引用
收藏
页码:1949 / 1954
页数:6
相关论文
共 50 条
  • [21] Predicting the outcomes of acute ischemic stroke in atrial fibrillation: The role of baseline CHADS2, CHA2DS2-VASc and HAS-BLED score values
    Padjen, V.
    Jovanovic, D. R.
    Berisavac, I. I.
    Ercegovac, M. D.
    Stanarcevic, P.
    Budimkic, M. Stefanovic
    Bumbasirevic, L. Beslac
    INTERNATIONAL JOURNAL OF STROKE, 2015, 10 : 277 - 277
  • [22] Prediction of long-term net clinical outcomes using the TIMI-AF score: Comparison with CHA2DS2-VASc and HAS-BLED
    Miguel Rivera-Caravaca, Jose
    Roldan, Vanessa
    Asuncion Esteve-Pastor, Maria
    Valdes, Mariano
    Vicente, Vicente
    Marin, Francisco
    Lip, Gregory Y. H.
    AMERICAN HEART JOURNAL, 2018, 197 : 27 - 34
  • [23] The HAS-BLED Score Has Better Prediction Accuracy for Major Bleeding Than CHADS2 or CHA2DS2-VASc Scores in Anticoagulated Patients With Atrial Fibrillation
    Roldan, Vanessa
    Marin, Francisco
    Manzano-Fernandez, Sergio
    Gallego, Pilar
    Antonio Vilchez, Juan
    Valdes, Mariano
    Vicente, Vicente
    Lip, Gregory Y. H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (23) : 2199 - 2204
  • [24] In anticoagulated patients with AF, HAS-BLED predicted major bleeding better than CHADS2 and CHA2DS2-VASc
    Marcucci, Maura
    ANNALS OF INTERNAL MEDICINE, 2014, 160 (10)
  • [25] Assessment and comparison of CHADS2, CHA2DS2-VASc, and HAS-BLED scores in patients with atrial fibrillation in Saudi Arabia
    Al-Turaiki, Abdulrahman M.
    Al-Ammari, Maha A.
    Al-Harbi, Shmeylan A.
    Khalidi, Nabil S.
    Alkatheri, Abdulmalik M.
    Aldebasi, Tariq M.
    AbuRuz, Salah M.
    Albekairy, Abdulkareem M.
    ANNALS OF THORACIC MEDICINE, 2016, 11 (02) : 146 - 150
  • [26] CHA2DS2-VASc and HAS-BLED risk scores and real-world oral anticoagulant prescribing decisions in atrial fibrillation
    Besford, Megan
    Leahy, Thomas P.
    Sammon, Cormac
    Ulvestad, Maria
    Carroll, Robert
    Mehmud, Faisal
    Alikhan, Raza
    Ramagopalan, Sreeram
    FUTURE CARDIOLOGY, 2021, 17 (05) : 855 - 864
  • [27] Translating claims-based CHA2DS2-VaSc and HAS-BLED to ICD-10-CM: Impacts of mapping strategies
    Webster-Clark, Michael
    Huang, Ting-Ying
    Hou, Laura
    Toh, Sengwee
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 (04) : 409 - 418
  • [28] Utility of CHA2DS2-VASc and HAS-BLED Scores as Predictor of Thromboembolism and Bleeding After Left Ventricular Assist Device Implantation
    Kemal, Hatice S.
    Ertugay, Serkan
    Nalbantgil, Sanem
    Ozturk, Pelin
    Engin, Cagatay
    Yagdi, Tahir
    Ozbaran, Mustafa
    ASAIO JOURNAL, 2017, 63 (06) : 720 - 724
  • [29] In AF, ABC scores predicted stroke or major bleeding better than CHA2DS2-VASc and HAS-BLED scores, respectively
    Kearon, Clive
    ANNALS OF INTERNAL MEDICINE, 2019, 170 (12) : JC71 - JC71
  • [30] Dynamic assessment of CHA2DS2-VASc and HAS-BLED scores for predicting ischemic stroke and major bleeding in atrial fibrillation patients
    Serna, Maria Jose
    Rivera-Caravaca, Jose Miguel
    Lopez-Galvez, Raquel
    Soler-Espejo, Eva
    Lip, Gregory Y. H.
    Marin, Francisco
    Roldan, Vanessa
    REVISTA ESPANOLA DE CARDIOLOGIA, 2024, 77 (10): : 835 - 842